SI
GPCR icon

Sofinnova Investments’s Structure Therapeutics GPCR Stock Holding History

Sofinnova Investments’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,353
Closed -$712K – 65
2025
Q2 		$712K Sell
34,353
-599
-2% -$13.2K 0.04% 60
2025
Q1 		$605K Buy
34,952
+14,060
+67% +$344K 0.04% 61
2024
Q4 		$567K Sell
20,892
-17,900
-46% -$635K 0.04% 59
2024
Q3 		$1.7M Buy
38,792
+29,877
+335% +$1.16M 0.14% 52
2024
Q2 		$350K Buy
8,915
+182
+2% +$7.47K 0.02% 80
2024
Q1 		$374K Sell
8,733
-166,105
-95% -$7M 0.02% 69
2023
Q4 		$7.13M Sell
174,838
-27,281
-13% -$1.56M 0.4% 38
2023
Q3 		$10.2M Buy
+202,119
New +$6.51M 0.64% 36

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sofinnova Investments's GPCR Position: Q3 2025 in Review

Sofinnova Investments sold out of Structure Therapeutics (GPCR) in Q3 2025, closing a stake of 34,353 shares — an estimated $712K sold.

Sofinnova Investments first reported a position in GPCR in Q3 2023 and held it in 8 quarters. The position peaked at $10.2M in Q3 2023. 156 funds tracked by Wall St. Rank hold GPCR as of Q3 2025.

  • Sofinnova Investments reported no remaining Structure Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Sofinnova Investments sold 34,353 Structure Therapeutics shares in Q3 2025, an estimated $712K.
  • Sofinnova Investments first reported a position in Structure Therapeutics in Q3 2023 and held it in 8 quarters.
  • Sofinnova Investments's Structure Therapeutics position peaked at $10.2M in Q3 2023.
  • 156 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2025.

Based on Sofinnova Investments's 13F filing for Q3 2025, filed 14 Nov 2025.